Author's reply to Weijers et al. "fibrin β15-42 domain is cryptic in intact fibrinogen: Comment on the study by A. Sahni et al."

International Journal of Cancer

Volumn 127, Issue 12, 2010, Pages 2982-2986

  Simpson Haidaris, Patricia J ^a   Sahni, Abha ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRIN BETA[15-42]; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; MONOMER; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

AMINO TERMINAL SEQUENCE; BREAST CANCER; BREAST EPITHELIUM; CELL INTERACTION; CELL MIGRATION; EXTRACELLULAR MATRIX; HUMAN; LETTER; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION;

EID: 78249244798     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25288     Document Type: Letter

References (39)

1. Sahni A, Arevalo MT, Sahni SK, Simpson-Haidaris PJ,. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells. Int J Cancer 2009; 125: 577 -84.
2. Weijers EM, Koolwijk P, van Hinsbergh VWM, van Nieuw Amerongen GP,. Fibrin β15-42 domain is cryptic in intact fibrinogen: comment on the study by A. Sahni et al. Int J Cancer 2010 [Epub ahead of print, Doi 10.1002/ijc.25280].
3. Dejana E, Orsenigo F, Lampugnani MG,. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121: 2115 -22.
4. Guadiz G, Sporn LA, Simpson-Haidaris PJ,. Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices. Blood 1997; 90: 2644 -53.
5. Rybarczyk BJ,. Fibrinogen and the extracellular matrix: biological implications in breast cancer. Ph.D. Thesis, Department of Pathology and Laboratory Medicine, The University of Rochester, New York, 2000.
6. Pereira M, Rybarczyk BJ, Odrljin TM, Hocking DC, Sottile J, Simpson-Haidaris PJ,. The incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J Cell Sci 2002; 115: 609 -17.
7. Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ,. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. Blood 2003; 102: 4035 -43.
8. 2-terminal region of fibrin. Mol Immunol 1984; 21: 89 -94.
9. Procyk R, Kudryk B, Callender S, Blomback B,. Accessibility of epitopes on fibrin clots and fibrinogen gels. Blood 1991; 77: 1469 -75.
10. Hamaguchi M, Bunce LA, Sporn LA, Francis CW,. Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading. Blood 1994; 84: 1143 -50.
11. Courtney MA, Bunce LA, Neroni LA, Simpson-Haidaris PJ,. Cloning of the complete coding sequence of rat fibrinogen Bβ chain cDNA: interspecies conservation of fibrin β15-42 primary structure. Blood Coagul Fibrinolysis 1994; 5: 487 -96.
12. Simpson-Haidaris PJ, Guadiz G, Odrljin TM,. Cell surface heparan sulfate proteoglycan-dependent fibrinogen assembly in extracellular matrix. Blood 1997;(, Supple 1 Part 1): 464a.
13. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, Bugge TH,. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96: 3302 -9.
14. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL,. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002; 62: 6966 -72.
15. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Jirouskova M, Degen JL,. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005; 105: 178 -85.
16. Palumbo JS, Degen JL,. Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. Thromb Res 2007; 120 (Suppl 2): S22 -8.
17. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA, Degen JL,. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 2007; 110: 133 -41.
18. Nierodzik ML, Karpatkin S,. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006; 10: 355 -62.
19. Bunce LA, Sporn LA, Francis CW,. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the β chain. J Clin Invest 1992; 89: 842 -50.
20. Sporn LA, Bunce LA, Francis CW,. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 1995; 86: 1802 -10.
21. Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS, Martinez J,. VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp Cell Res 1998; 238: 324 -34.
22. Odrljin TM, Francis CW, Sporn LA, Bunce LA, Marder VJ, Simpson-Haidaris PJ,. Heparin-binding domain of fibrin mediates its binding to endothelial cells. Arterioscler Thromb Vasc Biol 1996; 16: 1544 -51.
23. Odrljin TM, Shainoff JR, Lawrence SO, Simpson-Haidaris PJ,. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin β chain. Blood 1996; 88: 2050 -61.
24. Pereira M, Simpson-Haidaris PJ,. Fibrinogen modulates gene expression in wounded fibroblasts. Ann N Y Acad Sci 2001; 936: 438 -43.
25. Guadiz G, Sporn LA, Goss RA, Lawrence SO, Marder VJ, Simpson-Haidaris PJ,. Polarized secretion of fibrinogen by lung epithelial cells. Am J Respir Cell Mol Biol 1997; 17: 60 -9.
26. Simpson-Haidaris PJ,. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873 -82.
27. Nguyen MD, Simpson-Haidaris PJ,. Cell type-specific regulation of fibrinogen expression in lung epithelial cells by dexamethasone and IL-1β. Am J Respir Cell Mol Biol 2000; 22: 209 -17.
28. Rybarczyk BJ, Simpson-Haidaris PJ,. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res 2000; 60: 2033 -9.
29. Duan HO, Simpson-Haidaris PJ,. Cell type-specific differential induction of the human β-fibrinogen promoter by IL-6. J Biol Chem 2006; 281: 12451 -7.
30. Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW,. Fibrinogen synthesized by cancer cells augments the proliferative effect of FGF-2. J Thromb Haemost 2008; 6: 176 -83.
31. Lee SY, Lee KP, Lim JW,. Identification and biosynthesis of fibrinogen in human uterine cervix carcinoma cells. Thromb Haemost 1996; 75: 466 -70.
32. Molmenti EP, Ziambaras T, Perlmutter DH,. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268: 14116 -24.
33. Simpson-Haidaris PJ, Courtney MA,. Tissue-specific and ubiquitous expression of fibrinogen β-chain mRNA. Blood Coagul Fibrinolysis 1990; 1: 433 -7.
34. Courtney MA, Stoler MH, Marder VJ, Simpson-Haidaris PJ,. Developmental expression of mRNAs encoding platelet proteins in rat megakaryocytes. Blood 1991; 77: 560 -8.
35. Simpson-Haidaris PJ, Wright TW, Earnest BJ, Hui Z, Neroni LA, Courtney MA,. Cloning and characterization of a lung-specific cDNA corresponding to the β chain of hepatic fibrinogen. Gene 1995; 167: 273 -8.
36. Simpson-Haidaris PJ, Courtney MA, Wright TW, Goss R, Harmsen A, Gigliotti F,. Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia. Infect Immun 1998; 66: 4431 -9.
37. Pentecost BT, Bradley LM, Gierthy JF, Ding Y, Fasco MJ,. Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA. Mol Cell Endocrinol 2005; 238: 9 -25.
38. Tan YJ, Tham PY, Chan DZ, Chou CF, Shen S, Fielding BC, Tan TH, Lim SG, Hong W,. The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells. J Virol 2005; 79: 10083 -7.
39. Rescher U, Danielczyk A, Markoff A, Gerke V,. Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol 2002; 169: 1500 -4.